SHG:688621 - Beijing Sun-Novo Pharmaceutical Research Co Ltd

Beijing Sun Novo Pharmaceutica
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2017	2018	2019	2020	2021	2022	2023	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	493.65M 42.1%	676.61M 37.1%	932.12M 37.8%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	229.97M 31.4%	301.15M 31.0%	403.77M 34.1%
Gross Profit	[friend]	[friend]	[friend]	[friend]	263.68M 53.0%	375.46M 42.4%	528.35M 40.7%
Total Expenses	[friend]	[friend]	[friend]	[friend]	358.83M 37.3%	486.75M 35.6%	674.08M 38.5%
Operating Expense	[friend]	[friend]	[friend]	[friend]	128.87M 49.3%	185.6M 44.0%	270.31M 45.6%
Operating Income	[friend]	[friend]	[friend]	[friend]	134.81M 56.8%	189.86M 40.8%	258.04M 35.9%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	108.79M 46.7%	158.7M 45.9%	182.9M 15.2%
Net Income	[friend]	[friend]	[friend]	[friend]	105.66M 45.8%	156.47M 48.1%	184.76M 18.1%
Basic EPS	[friend]	[friend]	[friend]	[friend]	1.079 24.8%	1.4 29.8%	1.65 17.9%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	1.079 24.8%	1.4 29.8%	1.65 17.9%